0.7400
-0.0280
(-3.65%)
At close: April 16 at 1:09:26 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-19,274.4170
-19,274.4170
-15,448.9360
-20,969.3820
-13,335.0070
Investing Cash Flow
-1,401.3150
-1,401.3150
-4,090.9020
-5,405.3390
-3,267.4880
Financing Cash Flow
23,654.3980
23,654.3980
8,044.9570
34,301.9280
15,155.9940
End Cash Position
4,840.1470
4,840.1470
1,861.4810
13,356.3620
5,429.1550
Capital Expenditure
-1,407.0010
-1,407.0010
--
-3,867.6140
-135.6880
Issuance of Capital Stock
14,785.2030
14,785.2030
350
27,702.5980
15,156
Issuance of Debt
10,739.8560
10,739.8560
7,800
7,700
--
Repayment of Debt
--
--
--
-1,100
--
Repurchase of Capital Stock
--
--
--
-1,100
--
Free Cash Flow
-20,681.4180
-20,681.4180
-15,448.9360
-24,836.9960
-13,470.6950
12/31/2020 - 1/10/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LYTIX.OL Lytix Biopharma AS
5.0000
-4.58%
ALNEV.PA Neovacs S.A.
0.0219
-3.52%
NFX.L Nuformix plc
0.1325
0.00%
VYNE VYNE Therapeutics Inc.
1.8500
+2.49%
IBO Impact BioMedical Inc.
0.4026
-7.87%
JAGX Jaguar Health, Inc.
5.51
-2.13%
MTVA MetaVia Inc.
0.7390
+0.91%
AXSM Axsome Therapeutics, Inc.
104.46
-0.01%
CDT Conduit Pharmaceuticals Inc.
0.6201
-20.51%
ZLAB Zai Lab Limited
28.84
-0.33%